ArticleJournal of cancer research and clinical oncology2023

Eprinomectin: a derivative of ivermectin suppresses growth and metastatic phenotypes of prostate cancer cells by targeting the β-catenin signaling pathway.

Angela Samy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.